Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
HER2+ Metastatic Breast Cancer (MBC)
×
neratinib
×
Clear all
Filters
3
NCT01808573
2021-06-11
NALA
Puma Biotechnology, Inc.
Phase 3
Completed
621 enrolled
21 charts
2 FDA